Inhibition of Autophagy in Solid Tumors: A Phase I Pharmacokinetic and Pharmacodynamic Study of Hydroxychloroquine in Combination With the HDAC Inhibitor Vorinostat for the Treatment of Patients With Advanced Solid Tumors With an Expansion Study in Advanced Renal and Colorectal Cancer
Phase of Trial: Phase I
Latest Information Update: 02 May 2017
At a glance
- Drugs Hydroxychloroquine (Primary) ; Vorinostat (Primary)
- Indications Colorectal cancer; Renal cancer; Solid tumours
- Focus Adverse reactions
- 25 Apr 2017 Planned End Date changed from 1 Jan 2017 to 1 Jul 2017.
- 25 Apr 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Jul 2017.
- 20 Sep 2016 Planned End Date changed from 1 Jan 2016 to 1 Jan 2017.